Metropolitan Life Insurance Company (MetLife)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-49,667
Closed -$8.8M 2639
2020
Q1
$8.8M Sell
49,667
-190
-0.4% -$35.8K 0.18% 104
2019
Q4
$9.53M Buy
49,857
+146
+0.3% +$26.3K 0.15% 121
2019
Q3
$8.37M Buy
49,711
+2,427
+5% +$395K 0.14% 128
2019
Q2
$7.92M Buy
47,284
+2,400
+5% +$332K 0.13% 135
2019
Q1
$6.57M Sell
44,884
-1,724
-4% -$250K 0.12% 151
2018
Q4
$6.23M Sell
46,608
-421
-0.9% -$69K 0.12% 146
2018
Q3
$8.96M Buy
+47,029
New +$8.64M 0.15% 115
2015
Q4
Sell
-136,058
Closed -$37M 2658
2015
Q3
$37M Buy
+136,058
New +$41.8M 0.27% 68
2014
Q3
Sell
-105,845
Closed -$23.6M 2762
2014
Q2
$23.6M Sell
105,845
-4,684
-4% -$970K 0.16% 121
2014
Q1
$22.8M Sell
110,529
-1,619
-1% -$321K 0.16% 126
2013
Q4
$18.8M Buy
112,148
+821
+0.7% +$128K 0.13% 155
2013
Q3
$16M Buy
111,327
+26,330
+31% +$3.51M 0.12% 158
2013
Q2
$10.7M Buy
+84,997
New +$9.62M 0.09% 239

Other funds holding AGN

Metropolitan Life Insurance Company (MetLife)'s AGN Position: Q2 2020 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 49,667 shares — an estimated $8.8M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AGN in Q2 2013 and held it in 13 quarters. The position peaked at $37M in Q3 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 49,667 Allergan plc shares in Q2 2020, an estimated $8.8M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Allergan plc in Q2 2013 and held it in 13 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Allergan plc position peaked at $37M in Q3 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2020, filed 14 Aug 2020.